logo
Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk
More on risk/benefit ratio of anti-IL-2 receptor monoclonal antibodies
Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients
Impact of amino acid substitution at residue 9 of HLA-A2 on the development of acute GVHD in Korean pediatric patients receiving unrelated hematopoietic stem cell transplantation
Composite risk scores and depression as predictors of competing waiting-list outcomes: the Waiting for a New Heart Study
Screening colonoscopy and detection of neoplasia in asymptomatic, average-risk, solid organ transplant recipients: case-control study
Donor education campaigns since the introduction of the Dutch organ donation act: increased cohesion between campaigns has paid off
Comparison of surgical methods in liver transplantation: retrohepatic caval resection with venovenous bypass (VVB) versus piggyback (PB) with VVB versus PB without VVB
Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival
Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival
Cold ischemia contributes to the development of chronic rejection and mitochondrial injury after cardiac transplantation
Downregulation of cytolytic activity of human effector cells by transgenic expression of human PD-ligand-1 on porcine target cells